Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the Initial Clinical Data from Phase 1/2 RESET-Myositis and RESET-SLE Trials of CABA-201 in autoimmune diseases.

Ticker(s): CABA

Who's the expert?

Institution: Scripps Clinic

Department head for rheumatology
Manages around 75 patients for lupus
Practicing provider for over 20 years

Interview Goal

to discuss the current treatment landscape and the potential of CABA-201, a CAR T Cell Therapy being developed for the treatment of autoimmune diseases such as IMNM and SLE.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.